fluoxetine has been researched along with atomoxetine hydrochloride in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (24.00) | 18.2507 |
| 2000's | 4 (16.00) | 29.6817 |
| 2010's | 13 (52.00) | 24.3611 |
| 2020's | 2 (8.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Gackenheimer, SL; Gehlert, DR; Schober, DA | 1 |
| Kropp, BP; Springer, JP; Thor, KB | 1 |
| Gackenheimer, SL; Gehlert, DR; Robertson, DW | 1 |
| Bymaster, FP; Krushinski, JH; Mayle, DA; Reid, LR; Robertson, DW; Wong, DT | 1 |
| Bracher, F; Litz, T | 1 |
| Benvenga, MJ; Dreshfield, L; Fuller, RW; Gehlert, DR; Gleason, S; Hemrick-Luecke, SK; Tinsley, F; Wong, DT | 1 |
| Dluzen, DE; Shang, Y | 1 |
| Arnold, LE; Biederman, J; Duesenberg, D; Emslie, GJ; Gao, H; Kratochvil, CJ; Michelson, D; Newcorn, JH; Quintana, H; Sarkis, EH; Wagner, KD | 1 |
| Guo, B; He, MM; Li, C; Liu, H; Shen, H; Wang, L; Wrighton, SA | 1 |
| Barton, R | 1 |
| Cavanna, AE; Rickards, H; Worrall, R | 1 |
| Brecker, L; Kratzer, R; Nidetzky, B; Vogl, M | 1 |
| Achterberg, EJ; Schoffelmeer, AN; Schrama, L; Siviy, SM; Trezza, V; Vanderschuren, LJ | 1 |
| Martin, WJ; Obedencio, GP; Shen, F; Smith, JA; Tsuruda, PR | 1 |
| Buchwald, SL; Shi, SL | 1 |
| Hu, Q; Imamoto, T; Liu, Y; Zhang, W; Zhang, Z | 1 |
| Al-Mutairi, H; Al-Tajali, A; Naguy, A | 1 |
| Compagno, E; Di Cesare Mannelli, L; Ghelardini, C; Grassi, G; Micheli, L; Pallanti, S; Righi, L | 1 |
| Barygin, OI; Belinskaya, DA; Nagaeva, EI; Shestakova, NN; Tikhonov, DB; Vanchakova, NP | 1 |
| Hogan, MK; Rao, NP | 1 |
| Buchanan, GF; Dayton, KG; Kruse, SW; Purnell, BS; Rosner, JI | 1 |
| Anagnostaras, SG; Carmack, SA; Hammam, L; Pantoni, MM | 1 |
| Adil, KJ; Cheong, JH; Han, SH; Jeon, SJ; Kim, HJ; Kim, HY; Kim, R; Kwon, KJ; Mabunga, DFN; Park, D; Ryu, O; Shin, CY; Valencia, S | 1 |
1 review(s) available for fluoxetine and atomoxetine hydrochloride
| Article | Year |
|---|---|
Use of medication in children with psychiatric disorders.
Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Child Psychiatry; Drug Prescriptions; Drug Utilization; Fluoxetine; Fluvoxamine; Health Policy; Humans; Melatonin; Mental Disorders; Methylphenidate; Needs Assessment; Patient Selection; Practice Guidelines as Topic; Practice Patterns, Physicians'; Propylamines; Psychotropic Drugs; Risperidone; Sertraline; United Kingdom | 2007 |
1 trial(s) available for fluoxetine and atomoxetine hydrochloride
| Article | Year |
|---|---|
Atomoxetine alone or combined with fluoxetine for treating ADHD with comorbid depressive or anxiety symptoms.
Topics: Adolescent; Anxiety; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Depressive Disorder; Double-Blind Method; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Propylamines; Selective Serotonin Reuptake Inhibitors | 2005 |
23 other study(ies) available for fluoxetine and atomoxetine hydrochloride
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of (R)-[3H]tomoxetine and (R/S)-[3H]nisoxetine binding in rat brain.
Topics: Animals; Atomoxetine Hydrochloride; Autoradiography; Binding Sites; Brain; Citalopram; Desipramine; Fluoxetine; Male; Norepinephrine; Propylamines; Rats; Rats, Sprague-Dawley; Stereoisomerism; Tritium | 1995 |
Facilitatory and inhibitory effects of selective norepinephrine reuptake inhibitors on hypogastric nerve-evoked urethral contractions in the cat: a prominent role of urethral beta-adrenergic receptors.
Topics: Animals; Atomoxetine Hydrochloride; Cats; Dose-Response Relationship, Drug; Female; Fluoxetine; Muscle Contraction; Norepinephrine; Propranolol; Propylamines; Receptors, Adrenergic, beta; Urethra | 1994 |
Localization of rat brain binding sites for [3H]tomoxetine, an enantiomerically pure ligand for norepinephrine reuptake sites.
Topics: Animals; Atomoxetine Hydrochloride; Binding Sites; Desipramine; Fluoxetine; Kinetics; Ligands; Male; Nerve Tissue Proteins; Norepinephrine; Piperazines; Propylamines; Prosencephalon; Rats; Rats, Sprague-Dawley | 1993 |
Norfluoxetine enantiomers as inhibitors of serotonin uptake in rat brain.
Topics: Animals; Antidepressive Agents; Atomoxetine Hydrochloride; Brain; Dose-Response Relationship, Drug; Fluoxetine; Male; Paroxetine; Propylamines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Stereoisomerism | 1993 |
An efficient chemoenzymatic route to the antidepressants (R)-fluoxetine and (R)-tomoxetine.
Topics: Antidepressive Agents; Atomoxetine Hydrochloride; Enzymes; Fluoxetine; Magnetic Resonance Spectroscopy; Propylamines; Spectroscopy, Fourier Transform Infrared; Stereoisomerism | 1996 |
The selective norepinephrine reuptake inhibitor, LY368975, reduces food consumption in animal models of feeding.
Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Carrier Proteins; Eating; Fluoxetine; Male; Mice; Mice, Inbred ICR; Motor Activity; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Oxidopamine; Paroxetine; Propylamines; Rats; Rats, Sprague-Dawley; Symporters | 1998 |
Castration increases nisoxetine-evoked norepinephrine levels in vivo within the olfactory bulb of male rats.
Topics: Animals; Atomoxetine Hydrochloride; Extracellular Space; Fluoxetine; Male; Microdialysis; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Olfactory Bulb; Orchiectomy; Presynaptic Terminals; Propylamines; Rats; Rats, Sprague-Dawley; Reproduction; Sexual Behavior, Animal; Smell; Symporters; Testosterone; Up-Regulation | 2002 |
Comparative metabolic capabilities and inhibitory profiles of CYP2D6.1, CYP2D6.10, and CYP2D6.17.
Topics: Atomoxetine Hydrochloride; Cocaine; Codeine; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Debrisoquin; Dextromethorphan; Enzyme Inhibitors; Ethanolamines; Fluoxetine; Humans; Hydroxylation; Imipramine; Kinetics; Microsomes; Molecular Structure; Nortriptyline; Polymorphism, Single Nucleotide; Propylamines; Quinidine; Recombinant Proteins; Thioridazine; Tramadol | 2007 |
Treatment practices in Tourette syndrome: the European perspective.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Anxiety; Aripiprazole; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clonidine; Depression; Europe; Fluoxetine; Fluvoxamine; Health Care Surveys; Humans; Methylphenidate; Obsessive-Compulsive Disorder; Physicians; Piperazines; Propylamines; Psychiatry; Quinolones; Risperidone; Sertraline; Sulpiride; Tourette Syndrome | 2012 |
Candida tenuis xylose reductase catalyzed reduction of aryl ketones for enantioselective synthesis of active oxetine derivatives.
Topics: Acetophenones; Aldehyde Reductase; Atomoxetine Hydrochloride; Candida; Fluoxetine; Methanol; Molecular Structure; Oxidation-Reduction; Propylamines; Solubility; Substrate Specificity; Water | 2012 |
Amphetamine and cocaine suppress social play behavior in rats through distinct mechanisms.
Topics: Adrenergic Agents; Adrenergic alpha-2 Receptor Antagonists; Adrenergic Uptake Inhibitors; Amphetamine; Animals; Atomoxetine Hydrochloride; Behavior, Animal; Cocaine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Exploratory Behavior; Fluoxetine; Flupenthixol; Idazoxan; Male; Motor Activity; Piperazines; Play and Playthings; Propylamines; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Social Behavior | 2014 |
Relative contributions of norepinephrine and serotonin transporters to antinociceptive synergy between monoamine reuptake inhibitors and morphine in the rat formalin model.
Topics: Analgesia; Animals; Atomoxetine Hydrochloride; Biogenic Monoamines; Chromatography, Liquid; Drug Synergism; Duloxetine Hydrochloride; Fluoxetine; Formaldehyde; Morphine; Morpholines; Neurotransmitter Uptake Inhibitors; Nociceptive Pain; Norepinephrine Plasma Membrane Transport Proteins; Ondansetron; Propylamines; Rats; Rotarod Performance Test; Serotonin Plasma Membrane Transport Proteins; Tandem Mass Spectrometry; Thiophenes | 2013 |
Copper-catalysed selective hydroamination reactions of alkynes.
Topics: Alkynes; Amination; Amines; Atomoxetine Hydrochloride; Benzhydryl Compounds; Catalysis; Copper; Cresols; Duloxetine Hydrochloride; Fluoxetine; Phenylpropanolamine; Propylamines; Stereoisomerism; Thiophenes; Tolterodine Tartrate | 2015 |
ZnCl2 -promoted asymmetric hydrogenation of β-secondary-amino ketones catalyzed by a P-chiral Rh-bisphosphine complex.
Topics: Amination; Amino Alcohols; Atomoxetine Hydrochloride; Catalysis; Chlorides; Coordination Complexes; Duloxetine Hydrochloride; Fluoxetine; Hydrogenation; Ketones; Phosphines; Propylamines; Rhodium; Stereoisomerism; Thiophenes; Zinc Compounds | 2015 |
Atomoxetine-related Takotsubo Cardiomyopathy.
Topics: Adrenergic Uptake Inhibitors; Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Drug Interactions; Female; Fluoxetine; Humans; Selective Serotonin Reuptake Inhibitors; Takotsubo Cardiomyopathy | 2016 |
Atomoxetine for hoarding disorder: A pre-clinical and clinical investigation.
Topics: Adrenergic Uptake Inhibitors; Adult; Animals; Antidepressive Agents, Second-Generation; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Behavior, Animal; Disease Models, Animal; Female; Fluoxetine; Follow-Up Studies; Hoarding Disorder; Humans; Impulsive Behavior; Locomotion; Male; Mice; Middle Aged; Motor Activity; Psychiatric Status Rating Scales; Rotarod Performance Test; Statistics, Nonparametric | 2016 |
Inhibition of the NMDA and AMPA receptor channels by antidepressants and antipsychotics.
Topics: Amitriptyline; Animals; Antidepressive Agents; Antipsychotic Agents; Atomoxetine Hydrochloride; Brain; Chlorpromazine; Citalopram; Desipramine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Fluoxetine; Magnesium; Male; Membrane Potentials; N-Methylaspartate; Neurons; Neurotransmitter Agents; Rats, Wistar; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate | 2017 |
Case report: Cytochrome P450 implications for comorbid ADHD and OCD pharmacotherapy.
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents, Second-Generation; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Cytochromes; Fluoxetine; Humans; Male; Obsessive-Compulsive Disorder | 2017 |
Effect of monoamine reuptake inhibition and α
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Citalopram; Duloxetine Hydrochloride; Electroshock; Fluoxetine; Male; Mice; Mice, Inbred C57BL; Norepinephrine; Prazosin; Reboxetine; Seizures; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin and Noradrenaline Reuptake Inhibitors; Sudden Unexpected Death in Epilepsy | 2019 |
Dopamine and norepinephrine transporter inhibition for long-term fear memory enhancement.
Topics: Animals; Atomoxetine Hydrochloride; Behavior, Animal; Bupropion; Central Nervous System Stimulants; Conditioning, Classical; Dopamine Plasma Membrane Transport Proteins; Drug Therapy, Combination; Fear; Female; Fluoxetine; Male; Memory, Long-Term; Mice; Mice, Inbred C57BL; Neurotransmitter Uptake Inhibitors; Nootropic Agents; Norepinephrine Plasma Membrane Transport Proteins | 2020 |
Synergistic efficacy and diminished adverse effect profile of composite treatment of several ADHD medications.
Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Behavior, Animal; Disease Models, Animal; Dizocilpine Maleate; Dopamine Uptake Inhibitors; Drug Synergism; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; Fluoxetine; Growth and Development; Methylphenidate; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Open Field Test; Proto-Oncogene Proteins c-akt; Selective Serotonin Reuptake Inhibitors; Sleep | 2021 |